A Case of Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus Refractory to Epirubicin That Showed Marked Decrease in Tumor Markers after Transcatheter Arterial Infusion with Miriplatin

A Case of Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus Refractory to Epirubicin That Showed Marked Decrease in Tumor Markers after Transcatheter Arterial Infusion with Miriplatin

Miriplatin, a cisplatin derivative with a high affinity for iodized ethyl esters of fatty acids from poppy seed oil, is a novel chemotherapeutic agent designed for use in the transarterial treatment of hepatocellular carcinoma (HCC). Here, we describe transcatheter arterial infusion (TAI) using miri...

Full description

Bibliographic Details
Main Authors: Hiroki Nishikawa, Tadashi Inuzuka, Haruhiko Takeda, Jun Nakajima, Azusa Sakamoto, Sinichiro Henmi, Tetsurou Ishikawa, Sumio Saito, Ryuichi Kita, Toru Kimura, Yukio Osaki, Yorimitsu Koshikawa
Format: Article
Language:English
Published: Karger Publishers 2011-06-01
Series:Case Reports in Oncology
Subjects:
Miriplatin
Tumor marker
Hepatocellular carcinoma
Epirubicin
Online Access:http://www.karger.com/Article/FullText/330106

Similar Items

Similar Items